ASSESSMENT OF PATIENT-REPORTED OUTCOMES FROM A DOUBLE-BLIND TRIAL OF ETANERCEPT AND METHOTREXATE COMBINATION IN EARLY ACTIVE RHEUMATOID ARTHRITIS: THE COMET TRIAL

P. Durez, P. Emery, S. Hall, A. Koenig, R. Sato, A. Singh, D. Robertson, B. FreundlichCliniques Universitaires Saint-Luc, Universite Catholique de Louvain, Brussels, Belgium; University of Leeds, Leeds, United Kingdom; Cabrini Health Hospital, Malvern, Australia; Global Medical Affairs; Global Health Outcomes Assessment, Wyeth Research, Collegeville, United StatesCitation: Ann Rheum Dis, volume 67, supplement II, year 2008, page 605Session: RA – Anti-TNF therapy